Demand-related shortages for specific medicines in Canada due to the coronavirus pandemic have been acknowledged by the Canadian Generic Pharmaceutical Association and Biosimilars Canada, which said they were working with other key industry players to mitigate supply chain disruptions.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?